日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Rapid Active-Latent-Relapse Murine Model of Tuberculosis Based Blood Transcriptional Signature That Distinguishes Disease Stages

基于血液转录特征区分结核病疾病阶段的快速活动-潜伏-复发小鼠模型

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms27062554
Li, Haifeng; Wang, Junfei; Wang, Yu; Liu, Fan; Tang, Jun; Sun, Mengmeng; Zhan, Lingjun
发表日期：2026
文献求助 收藏

CRISPR Screening and Comparative LC-MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis.

CRISPR 筛选和比较 LC-MS 分析鉴定出介导 Delamanid 和 Pretomanid 对结核分枝杆菌疗效的基因

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202400176
Yan Mei-Yi, Li Haifeng, Qu Yun-Mo, Li Si-Shang, Zheng Dandan, Guo Xiao-Peng, Wu Zhaojun, Lu Jie, Pang Yu, Li Weimin, Yang Jian, Zhan Lingjun, Sun Yi-Cheng
其它
肠道菌群
发表日期：2024
文献求助 收藏

Flu-CED: A comparative transcriptomics database of influenza virus-infected human and animal models

Flu-CED：流感病毒感染的人类和动物模型的比较转录组学数据库

期刊:Animal Models and Experimental Medicine
影响因子:3.4
doi:10.1002/ame2.12384
Wu, Yue; Wang, Jue; Xue, Jing; Xiang, Zhiguang; Guo, Jianguo; Zhan, Lingjun; Wei, Qiang; Kong, Qi
炎症/感染
流感
微生物学
发表日期：2024
文献求助 收藏

The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice

ATIR阻滞剂对高血压住院患者COVID-19病情严重程度及SARS-CoV-2在高血压hACE2转基因小鼠中毒力的影响

期刊:Journal of Cardiovascular Translational Research
影响因子:2.5
doi:10.1007/s12265-021-10147-3
Jiang, Xiaoliang; Li, Huadong; Liu, Yong; Bao, Linlin; Zhan, Lingjun; Gao, Hong; Deng, Wei; Xue, Jing; Liu, Jiangning; Liu, Xing; Li, Junli; Wang, Jie; Wu, Shuang; Yan, Mingzhe; Luo, Wei; Jose, Pedro A; Qin, Chuan; Yang, Xiuhong; Zhang, Dingyu; Yang, Zhiwei
心血管
ACE2
高血压
SARS-CoV-2
发表日期：2022
文献求助 收藏

Exercise mimetics and JAK inhibition attenuate IFN-γ-induced wasting in engineered human skeletal muscle

运动模拟物和 JAK 抑制可减轻 IFN-γ 诱导的工程化人类骨骼肌萎缩

期刊:Science Advances
影响因子:11.7
doi:10.1126/sciadv.abd9502
Zhaowei Chen, Binjie Li, Ren-Zhi Zhan, Lingjun Rao, Nenad Bursac
信号转导
JAK/STAT
Human
发表日期：2021
文献求助 收藏

Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells

HDAC作为表观遗传重塑和免疫细胞功能潜在靶点的临床前和临床研究进展

期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.62001
Zhang, Sijia; Zhan, Lingjun; Li, Xue; Yang, Zhenhong; Luo, Yumin; Zhao, Haiping
细胞生物学
表观遗传
免疫/内分泌
发表日期：2021
文献求助 收藏

Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium

通过上调JAK/STAT信号导致肌节蛋白丢失是干扰素-γ诱导的工程化人类心肌收缩功能障碍的基础

期刊:Acta Biomaterialia
影响因子:9.4
doi:10.1016/j.actbio.2021.03.007
Ren-Zhi Zhan, Lingjun Rao, Zhaowei Chen, Nicholas Strash, Nenad Bursac
信号转导
JAK/STAT
发表日期：2021
文献求助 收藏

The double-sided effects of Mycobacterium Bovis bacillus Calmette-Guérin vaccine

牛分枝杆菌卡介苗的双重效应

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-020-00278-0
Li, Junli; Zhan, Lingjun; Qin, Chuan
发表日期：2021
文献求助 收藏

Whole Genome and Transcriptome Sequencing of Two Multi-Drug Resistant Mycobacterium tuberculosis Strains to Facilitate Illustrating Their Virulence in vivo

对两种多重耐药结核分枝杆菌菌株进行全基因组和转录组测序，以阐明其体内毒力。

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2020.00219
Tang, Jun; Liu, Zhihao; Shi, Ya'nan; Zhan, Lingjun; Qin, Chuan
发表日期：2020
文献求助 收藏

Tuberculosis vaccine development: from classic to clinical candidates

结核病疫苗研发：从经典疫苗到临床候选疫苗

期刊:European Journal of Clinical Microbiology & Infectious Diseases
影响因子:3
doi:10.1007/s10096-020-03843-6
Li, Junli; Zhao, Aihua; Tang, Jun; Wang, Guozhi; Shi, Yanan; Zhan, Lingjun; Qin, Chuan
发表日期：2020
文献求助 收藏